TDOC Teladoc Health, Inc.

XNYS 6.24 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

TDOC $6.24 —
Key stats
$6.24
52-Week Range
$4.40 – $9.89
YTD
-11.49%
IV Rank (30D)
45.26
Straddle Price
$1.04
P/C Vol Ratio
0.12
Market Cap
$1.2B
Open
$6.32
Day Range
$6.14 – $6.38
Volume
3,398,206
Prev Close
$6.34
Fair Value
+50.0% vs price

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.13%
Beta vs SPY1.66
Cost of Equity (CAPM)14.27% (VRP-adj)
WACC14.32%
Volatility Risk Premium+53.8pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)-3.1%
DCF Horizon10 years explicit + fade
Free Cash Flow (TTM)$0.2B
Return on Equity (TTM)-13.5%
Book / Price115.9% — banking bias active (P/B is primary)
Gross Margin (TTM)69.0%
FCF Margin (TTM)7.8%
Debt / Equity0.00
Quality Score3/6 — normal (10y DCF)
SMA 50$6.16 (Market Anchor value)
SMA 20 / Bollinger Mid$5.87
Bollinger Width / SMA20288.2% (drives anchor stability)
Net Debt$-0.8B
Market Cap$1B
Peers used for multiples: AIRS, HIMS, LFMD, SBC, TOI (SIC-code peers; ETF co-membership was sector-incoherent)
Blended Fair Value
$17.14
Deviation
+50.0%
MethodImplied PriceWeightDetail
DCF $11.39 40%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B $56.42 16% median 7.7× · 4 peers
Peer P/S $12.15 16% median 0.9× · 5 peers
Market Anchor (SMA50) $6.16 0% stability 0% (BB-width)
Options Expected (B-L 30d) $6.24 28% 14 strikes · skew +0.16
As of 2026-10-26 · updated
About
Industry (SIC)
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE (8011) · industry map
Exchange
XNYS
Market Cap
$1.2B
Employees
5,600
List Date
2015-07-01
CIK
0001477449
Next Earnings
2026-10-28 (After-Close)
EPS Forecast
($0.23) (6 est.)
Headquarters
New York, NY
Homepage
https://www.teladochealth.com

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including coun…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan31.50%-19.32%30.20%-11.40%6.72%-22.70%2.50%
Feb-16.29%-5.51%-13.83%-23.99%-4.88%-2.05%-11.09%
Mar-18.64%-2.80%0.08%0.67%-15.59%5.62%-5.11%
Apr-5.71%-54.24%3.59%-14.14%-7.35%14.77%-10.51%
May-7.74%-8.21%-14.48%-12.26%-1.00%17.80%-4.32%
Jun9.14%1.81%6.25%-11.73%26.78%7.21%6.58%
Jul-9.83%5.80%16.24%1.18%-15.97%-26.30%-4.81%
Aug-3.76%-15.62%-18.41%-16.53%11.38%-5.09%-8.01%
Sep-12.95%-17.69%-18.71%24.39%1.18%-7.35%-5.19%
Oct18.06%14.57%-10.26%1.58%10.64%10.05%*7.44%
Nov-33.18%-1.28%8.95%30.08%-6.76%---0.44%
Dec-1.73%-18.45%13.60%-20.96%-5.91%---6.69%
Total-50.20%-78.52%-9.50%-50.54%-8.41%-17.33%-35.75%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $5.88
SMA 50: $6.14
SMA 200: $6.46
Current: $6.24
EMA 12: $6.08
EMA 26: $6.07
MACD: 0.0143 | Signal: 0.0917
BEARISH
ADX (14): 16.86
RANGE
+DI: 28.24
−DI: 22.50

Momentum Oscillators

RSI (14): 54.66
NEUTRAL
Stoch %K: 89.34
Stoch %D: 91.48
Williams %R: -16.75

Volume & Volatility

BB Upper: $6.41
BB Lower: $5.36
NEUTRAL
OBV: -61,303,704
Vol SMA 20: 3,607,561
Vol ROC: 4.42%
ATR: $0.25
True Range: $0.24
HV 20: 50.7%
HV 30: 45.1%
HV 60: 44.0%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis

LLM Stock Analysis Report

SYMBOL: TDOC

Executive Summary

Overall assessment: NEUTRAL with confidence level (6/10)

Key drivers: Recent news sentiment, technical signals from momentum oscillators, and volatility regime

Primary risks: Bearish MACD signal, potential oversold RSI reading, high implied volatility

Investment thesis: Teladoc Health's stock price may experience short-term volatility due to mixed market sentiment and recent news headlines. The company's virtual care practice built around the person (positive news) may counterbalance the bearish momentum signals.

Recent news sentiment impact: The negative news headline from July 30 contributed to a short-term decline in the stock price, while the positive news from July 23 may have boosted the stock.

Technical Analysis

Trend direction:

  • Short-term (1-4 weeks): Bearish
  • Medium-term (1-3 months): Neutral
  • Long-term (3-12 months): Bullish

Support/resistance levels: Key price levels from moving averages and technical patterns are $7.54 (EMA 12), $8.16 (SMA 50), and $10.87 (Bollinger Bands upper band).

Momentum signals:

  • RSI interpretation: Neutral at 39.14, but may become oversold if it reaches 30-40
  • MACD signal: Bearish, indicating a potential downtrend
  • Bollinger Bands position: Squeeze, suggesting volatility is about to increase

Volume analysis: Volume trends and institutional interest signals suggest moderate volume flow (119 calls vs 24 puts) with an open interest of 71 calls vs 211 puts. The put/call ratio is 0.20, indicating a bullish sentiment.

News & Sentiment Analysis

Recent headlines summary:

  • Positive news: Teladoc Health introduces virtual care practice built around the person
  • Negative news: Insider sells $71,000 worth of Telehealth stock, Microsoft Soars 15% boosting tech stocks

Sentiment assessment: The overall sentiment is NEUTRAL due to mixed market commentary.

Catalyst identification: Upcoming earnings report and potential regulatory changes may impact the stock price.

Market narrative: News headlines align with technical signals, suggesting a potentially volatile market.

Risk & Volatility Assessment

Beta interpretation:

  • Beta: 1.23 (vs SPY), indicating high risk relative to the market

Volatility regime:

  • Current volatility level is high at 0.64
  • Historical volatility levels are 131.2% (HV20) and 112.9% (HV30)

Options market signals:

  • IV rank: Medium (32.6%), showing historically high implied volatility
  • Current IV: 149.2%, indicating a potentially richly priced option

Downside protection: Support levels at $7.54 (EMA 12) and $8.16 (SMA 50) should be monitored.

Market Context & Positioning

Sector performance:

  • Healthcare Services sector is performing positively with an R-squared of 0.85

Institutional activity:

  • Moderate volume flow suggests institutional interest, but open interest is relatively low

Correlation analysis:

  • The stock moves moderately relative to the market (R-squared: 0.25)

Relative valuation:

  • The stock is positioned within a trading range between $5.94 and $10.87.

Key Levels & Action Items

Critical price levels:

  • Support/resistance at $7.54, $8.16, and $10.87

Breakout/breakdown levels:

  • Technical levels that could trigger significant moves are the Bollinger Bands upper band ($10.87) and lower band ($5.94)

Time-sensitive catalysts:

  • Earnings report and potential regulatory changes may impact the stock price.

Risk management:

  • Stop-loss levels should be set at $6.50 (30% below current price)
  • Position sizing considerations: 1/3 long, 2/3 short
Generated
Earnings History
12 of 22 under expected move
Avg Expected Move
11.84%
Avg Actual Move
11.23%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-02-24 After-Close 7.59% 13.74% 1.81x Exceeded
2021-04-28 After-Close 7.61% 8.29% 1.09x Exceeded
2021-07-27 After-Close 6.95% 0.53% 0.08x Within
2021-10-27 After-Close 6.60% 7.61% 1.15x Exceeded
2022-01-10 After-Close 7.14% 5.04% 0.71x Within
2022-04-27 After-Close 13.48% 40.15% 2.98x Exceeded
2022-07-27 After-Close 16.30% 17.67% 1.08x Exceeded
2022-10-26 After-Close 17.95% 6.47% 0.36x Within
2023-01-09 After-Close 7.54% 2.84% 0.38x Within
2023-04-26 After-Close 13.00% 6.36% 0.49x Within
2023-07-25 After-Close 13.48% 26.95% 2.00x Exceeded
2023-10-24 After-Close 13.80% 3.92% 0.28x Within
2024-02-20 After-Close 16.94% 23.67% 1.40x Exceeded
2024-07-31 After-Close 16.33% 8.91% 0.55x Within
2024-10-30 After-Close 14.73% 1.58% 0.11x Within
2025-02-26 After-Close 17.02% 13.56% 0.80x Within
2025-04-30 After-Close 13.77% 2.78% 0.20x Within
2025-07-29 After-Close 12.08% 1.73% 0.14x Within
2025-10-23 After-Close 3.66% 10.00% 2.73x Exceeded
2026-02-25 After-Close 11.40% 15.05% 1.32x Exceeded
2026-04-29 After-Close 11.18% 1.85% 0.17x Within
2026-07-29 After-Close 11.87% 28.32% 2.39x Exceeded

Earnings calendar: this week’s reports with expected vs actual moves →

TDOC Options Activity & IV Rank

TDOC IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 72.0%
7-DTE IV: 95.2%
Expected Move: $1.04
7-DTE Move: $0.71
Days to Exp: 32 (2026-11-27)

Options Flow

Call Volume: 190
Put Volume: 23
P/C Volume: 0.121
BULLISH
Call OI: 311
Put OI: 31
P/C OI: 0.1
Total OI: 342

ATM Options Pricing

ATM Call: $0.63
ATM Put: $0.41
Call %: 10.1%
Put %: 6.5%

Chain Summary

Chain Volume: 4,644
Chain OI: 183,965
Last Updated: 10/26/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 47th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
47%
vs own history
GEX tilt
+0.18
OI-weighted, today
Vanna tilt
+0.60
δ-sensitivity to IV
Charm tilt
-0.52
δ-decay vs time
Vanna tilt +0.60: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.52: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 31 ATM contracts, 25k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d 85%
+14.6 pts EXTREME
as of Oct 26 · ATM 89.5% / Wing 104.2%
30 DTE / 10d —
— pts EXTREME
as of Oct 26 · ATM 69.5% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)70.5MediumOct 26
IV Rank (30 DTE)45.3MediumOct 26
Straddle Price (30 DTE)$1.04Oct 26
Beta Analysis

Risk Metrics

Beta: 1.0402
Alpha: -36.61%
Correlation: 0.2204
R-Squared: 4.9%
Stock Volatility: 60.2%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Above average volatility - stock moves with market amplification
Beta & Alpha Over Time
Notable investors who own TDOC
7 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Point72 Hedge fund
Steve Cohen
$69.9M
0.11%
#239 of 1945+6.7%13F
Renaissance Technologies Hedge fund
Jim Simons
$68.5M
0.09%
#240 of 3138-0.2%13F
Oaktree Capital Asset manager
Howard Marks
$52.3M
0.99%
#32 of 130+62.2%13F
Citadel Hedge fund
Ken Griffin
$6.5M
0.00%
#1888 of 6285+31.1%13F
Millennium Management Hedge fund
Izzy Englander
$1.2M
0.00%
#2823 of 3716new13F
Bridgewater Associates Hedge fund
Ray Dalio
$100K
0.00%
#996 of 997+0.4%13F
Rockefeller Capital Management Family office
Rockefeller family
$100K
0.00%
#2992 of 4729+45.9%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

TDOC Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 178,326,145 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

378 filers1,174,580,431 shares$2.43B value658.67% of float
# Filer Shares Value % of Total % of Float Period
1 TENOR CAPITAL MANAGEMENT Co., L.P. 186,000,000 $181.30M 7.47% 104.30% 2026-06-30
2 BlackRock, Inc. Custodian 35,538,134 $156.30M 6.44% 19.93% 2026-06-30
3 D. E. Shaw & Co., Inc. Custodian 150,556,209 $151.53M 6.24% 84.43% 2026-06-30
4 Vanguard Group Inc Custodian 21,483,707 $150.39M 6.19% 12.05% 2025-12-31
5 Vanguard Portfolio Management LLC 12,685,592 $107.57M 4.43% 7.11% 2026-06-30
6 Context Capital Management, LLC 105,459,000 $102.77M 4.23% 59.14% 2026-06-30
7 ARISTEIA CAPITAL, L.L.C. 77,338,000 $75.37M 3.10% 43.37% 2026-06-30
8 DeepCurrents Investment Group LLC 73,000,000 $71.03M 2.92% 40.94% 2026-06-30
9 Point72 Asset Management, L.P. 8,239,927 $69.87M 2.88% 4.62% 2026-06-30
10 RENAISSANCE TECHNOLOGIES LLC 8,072,842 $68.46M 2.82% 4.53% 2026-06-30
11 Voss Capital, LP 8,046,679 $68.24M 2.81% 4.51% 2026-06-30
12 State Street Corp 31,568,382 $67.99M 2.80% 17.70% 2026-06-30
13 Vanguard Capital Management LLC 7,955,032 $67.46M 2.78% 4.46% 2026-06-30
14 Dimensional Fund Advisors LP Custodian 7,371,699 $62.52M 2.57% 4.13% 2026-06-30
15 CAMDEN ASSET MANAGEMENT L P /CA 62,641,000 $60.73M 2.50% 35.13% 2026-06-30
16 Radcliffe Capital Management, L.P. 62,281,700 $60.62M 2.50% 34.93% 2026-06-30
17 OAKTREE CAPITAL MANAGEMENT LP 53,624,000 $52.26M 2.15% 30.07% 2026-06-30
18 Opti Capital Management, LP 50,000,000 $48.75M 2.01% 28.04% 2026-06-30
19 Marshall Wace, LLP Custodian 46,073,292 $45.34M 1.87% 25.84% 2026-06-30
20 American Century Companies, Inc. 4,894,504 $41.51M 1.71% 2.74% 2026-06-30
21 Allianz Asset Management GmbH 4,666,596 $39.57M 1.63% 2.62% 2026-06-30
22 Geode Capital Management, LLC Custodian 4,653,834 $39.47M 1.63% 2.61% 2026-06-30
23 Goldman Sachs Group Inc Custodian 3,822,284 $32.41M 1.33% 2.14% 2026-06-30
24 Monaco Asset Management SAM 3,167,979 $26.86M 1.11% 1.78% 2026-06-30
25 JUPITER ASSET MANAGEMENT LTD 3,109,714 $26.37M 1.09% 1.74% 2026-06-30
24 filers$77.45M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $16.44M 21.22% 2026-06-30
2 IMC-Chicago, LLC Custodian $7.99M 10.32% 2026-06-30
3 GROUP ONE TRADING LLC Custodian $7.52M 9.71% 2026-06-30
4 Voss Capital, LP $5.94M 7.66% 2026-06-30
5 PEAK6 LLC $5.23M 6.75% 2026-06-30
6 Citadel Advisors LLC Custodian $5.11M 6.60% 2026-06-30
7 Squarepoint Ops LLC $5.09M 6.57% 2026-06-30
8 ORACLE INVESTMENT MANAGEMENT INC $4.55M 5.87% 2025-12-31
9 Wolverine Trading, LLC Custodian $3.61M 4.66% 2025-09-30
10 Parallax Volatility Advisers, L.P. $3.39M 4.38% 2026-06-30
11 Simplex Trading, LLC Custodian $2.83M 3.66% 2026-06-30
12 Soviero Asset Management, LP $2.44M 3.15% 2026-06-30
13 Jane Street Group, LLC Custodian $2.16M 2.78% 2026-06-30
14 UBS Group AG Custodian $1.70M 2.19% 2026-06-30
15 Walleye Capital LLC $1.08M 1.40% 2026-06-30
16 Caption Management, LLC $593.60K 0.77% 2026-06-30
17 BNP Paribas Financial Markets Custodian $551.20K 0.71% 2026-06-30
18 D. E. Shaw & Co., Inc. Custodian $495.23K 0.64% 2026-06-30
19 Parker Investment Management, LLC $276.45K 0.36% 2026-06-30
20 Walleye Trading LLC $172.14K 0.22% 2026-06-30
21 TUDOR INVESTMENT CORP ET AL $133.14K 0.17% 2026-06-30
22 SIG BROKERAGE, LP $84.80K 0.11% 2026-06-30
23 Point72 Asset Management, L.P. $61.06K 0.08% 2026-06-30
24 Raiffeisen Bank International AG $8.99K 0.01% 2026-06-30
17 filers$51.14M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $11.71M 22.90% 2026-06-30
2 Citadel Advisors LLC Custodian $6.80M 13.29% 2026-06-30
3 Jane Street Group, LLC Custodian $5.09M 9.95% 2026-06-30
4 IMC-Chicago, LLC Custodian $3.87M 7.56% 2026-06-30
5 Simplex Trading, LLC Custodian $3.08M 6.03% 2026-06-30
6 JPMorgan Chase & Co Custodian $2.78M 5.44% 2026-06-30
7 Squarepoint Ops LLC $2.76M 5.40% 2026-06-30
8 Crawford Fund Management, LLC $2.66M 5.21% 2026-06-30
9 D. E. Shaw & Co., Inc. Custodian $2.54M 4.97% 2026-06-30
10 GROUP ONE TRADING LLC Custodian $2.46M 4.82% 2026-06-30
11 Wolverine Trading, LLC Custodian $2.06M 4.03% 2025-09-30
12 NOMURA HOLDINGS INC $1.70M 3.32% 2026-06-30
13 Walleye Trading LLC $1.28M 2.50% 2026-06-30
14 Balyasny Asset Management L.P. $1.23M 2.40% 2026-06-30
15 Walleye Capital LLC $989.62K 1.94% 2026-06-30
16 BNP Paribas Financial Markets Custodian $132.29K 0.26% 2026-06-30
17 Point72 Asset Management, L.P. $848 <0.01% 2026-06-30

TDOC Insider Trading (Form 4)

Latest: 2026-10-05
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-05 Joseph Ronald Catapano Chief Accounting Officer Mixed +1,428 $5.65 -$3.7K EDGAR
2026-09-14 Charles Divita III CHIEF EXECUTIVE OFFICER Mixed +24,997 $6.10 -$108.7K EDGAR
2026-09-03 Joseph Ronald Catapano Chief Accounting Officer Mixed +598 $6.30 -$1.7K EDGAR
2026-09-03 Charles Divita III CHIEF EXECUTIVE OFFICER Mixed +25,916 $6.30 -$115.5K EDGAR
2026-09-03 Carlos Nueno President, International Mixed +7,073 $6.30 -$39.1K EDGAR
2026-09-03 Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY Mixed +7,355 $6.30 -$47.7K EDGAR
2026-09-03 Kelly Bliss President, U.S. Group Health Mixed +7,954 $6.30 -$46.4K EDGAR
2026-09-03 Fernando M. Rodrigues President of BetterHelp Mixed — $6.44 -$98.1K EDGAR
2026-09-01 Michael F Grasher Chief Financial Officer Grant (A) +239,616 RSU — EDGAR
2026-08-04 Mark V Anquillare Director Grant (A) +37,425 RSU — EDGAR
2026-07-06 Kelly Bliss President, U.S. Group Health Sell (S) −2,500 $9.50 -$23.8K EDGAR
2026-07-06 Joseph Ronald Catapano Chief Accounting Officer Mixed +1,430 $9.10 -$5.9K EDGAR
2026-07-01 Kelly Bliss President, U.S. Group Health Sell (S) −2,500 $9.00 -$22.5K EDGAR
2026-06-12 Charles Divita III CHIEF EXECUTIVE OFFICER Mixed +24,728 $6.94 -$125.5K EDGAR
2026-06-04 Fernando M. Rodrigues President of BetterHelp Sell (S) −9,572 $7.40 -$70.8K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

TDOC Insider Holdings

15 insiders · @ $6.24
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Charles Divita III CHIEF EXECUTIVE OFFICER 465,535 $2.90M -$1.16M 11 2026-09-14
2 David B Snow Jr Director 165,032 $1.03M $0 16 2026-05-21
3 Mala Murthy CHIEF FINANCIAL OFFICER 142,835 $891.3K -$4.53M 26 2025-09-03
4 Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY 115,611 $721.4K -$27.58M 66 2026-09-03
5 Kelly Bliss President, U.S. Group Health 89,737 $560.0K -$529.4K 13 2026-09-03
6 Catherine Jacobson Director 66,853 $417.2K $0 10 2026-05-21
7 Carlos Nueno President, International 62,227 $388.3K -$429.5K 9 2026-09-03
8 David L Shedlarz Director 61,266 $382.3K -$6.61M 16 2026-05-21
9 Thomas McKinley Director 57,098 $356.3K -$9.46M 22 2025-05-23
10 Sandra L Fenwick Director 40,702 $254.0K -$1.68M 15 2026-05-21
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

TDOC Board & Officers

As of SEC filings through Oct 5, 2026

Directors 10

Officers 7

Changes in the last 10 years (63)
Aug 31, 2026Michael F Grasher became Chief Financial Officer
Aug 3, 2026Mark V Anquillare became a director
Mar 30, 2026Susan R Salka became a director
Feb 18, 2026Michael S Smith became a director
Feb 8, 2026The company announced the departure of Thomas McKinley from the board in an SEC filing
Dec 11, 2025The company announced the departure of Jason Eric Evans from the board in an SEC filing
Oct 17, 2025The company announced the departure of Mala Murthy as Chief Financial Officer in an SEC filing
Sep 27, 2024The company announced the departure of Michael Willem Waters as Chief Operating Officer in an SEC filing
Sep 25, 2024Kelly Bliss became President, U.S. Group Health
Sep 25, 2024Fernando M. Rodrigues became President of BetterHelp
Sep 25, 2024Carlos Nueno became President, International
Sep 9, 2024Joseph Ronald Catapano became Chief Accounting Officer
Sep 5, 2024Andrew Turitz reported in an SEC filing no longer being EVP, Corporate Development
Sep 4, 2024Mala Murthy listed as Chief Financial Officer (previously Acting CEO, CFO) in SEC filings
Aug 5, 2024Laizer Kornwasser reported in an SEC filing no longer being President, Enterprise Growth
Jun 10, 2024Charles Divita III became a director
Jun 10, 2024Charles Divita III became Chief Executive Officer
May 24, 2024Karen L Daniel reported in an SEC filing no longer being a director
May 4, 2024James L. Cave became Interim CAO
Apr 8, 2024The company announced the departure of Richard J Napolitano as Chief Accounting Officer in an SEC filing
Not reported recently (27)
  • Vidya Raman-Tangella · Last reported as Chief Medical Officer in an SEC filing dated Sep 5, 2024
  • Stephany Verstraete · Last reported as Chief Marketing Officer in an SEC filing dated Sep 4, 2024
  • Arnnon Geshuri · Last reported as Chief People Officer in an SEC filing dated Sep 4, 2024
  • Daniel Trencher · Last reported as Chief Strategy Officer in an SEC filing dated Sep 4, 2024
  • Nikolaos P. Nanis · Last reported as Chief Technology Officer in an SEC filing dated Sep 4, 2024
  • James L. Cave · Last reported as Interim CAO in an SEC filing dated Sep 4, 2024
  • Jason N Gorevic · Last reported as Chief Executive Officer in an SEC filing dated Mar 20, 2024
  • William H. Frist · Last reported as a director in an SEC filing dated May 31, 2022
  • Christopher Bischoff · Last reported as a director in an SEC filing dated May 18, 2022
  • David William Sides · Last reported as Chief Operating Officer in an SEC filing dated Aug 2, 2021
  • Hemant Taneja · Last reported as a director in an SEC filing dated Apr 21, 2021
  • Glen Tullman · Last reported as a director in an SEC filing dated Apr 2, 2021
  • Yulun Wang · Last reported as Head of Research & Development in an SEC filing dated Jan 27, 2021
  • Lewis Levy · Last reported as Chief Medical Officer in an SEC filing dated Oct 5, 2020
  • Michelle Bucaria · Last reported as Chief Human Resources Officer in an SEC filing dated Sep 2, 2020
  • Christopher Caridi · Last reported as Chief Accounting Officer in an SEC filing dated Jul 10, 2020
  • Michael Goldstein · Last reported as a director in an SEC filing dated Jun 15, 2020
  • Helen Darling · Last reported as a director in an SEC filing dated Jun 15, 2020
  • Gabriel R. Cappucci · Last reported as Senior VP, Controller and CAO in an SEC filing dated Apr 17, 2020
  • Peter A McClennen · Last reported as President in an SEC filing dated Jul 19, 2019
  • Arneek Multani · Last reported as a director in an SEC filing dated Jun 3, 2019
  • Brian P McAndrews · Last reported as a director in an SEC filing dated Jun 3, 2019
  • Mark Hirschhorn · Last reported as Executive VP, COO and CFO in an SEC filing dated Dec 17, 2018
  • Tom Mawhinney · Last reported as a director in an SEC filing dated May 30, 2018
  • David Schloss · Last reported as Chief Human Resources Officer in an SEC filing dated Jan 11, 2018
  • Michael H. King · Last reported as Chief Sales Officer in an SEC filing dated May 30, 2017
  • Peter N. Nieves · Last reported as EVP and CRO in an SEC filing dated Mar 15, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

TDOC Proposed Insider Sales (Form 144)

Latest: 2026-09-11
Last 30d: 0 filings  ·  Last 90d: 2 filings · $173K notice value · 2 unique filers · 50% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: DIVITA CHARLES III (1, $109K) · Rodrigues Fernando M. (1, $64K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-09-11 DIVITA CHARLES III Officer, Director 17,805 $108.7K 2026-09-11 Fidelity Brokerage Services LLC — EDGAR
2026-09-03 Rodrigues Fernando M. Officer 9,812 $63.9K 2026-09-03 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2026-07-06 Bliss Kelly Officer 2,500 $23.8K 2026-07-06 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2026-07-01 Bliss Kelly Officer 2,500 $22.5K 2026-07-01 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2026-06-29 Bliss Kelly Officer 2,500 $21.2K 2026-06-29 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2026-06-11 DIVITA CHARLES III Officer, Director 18,074 $125.5K 2026-06-11 Fidelity Brokerage Services LLC — EDGAR
2026-06-03 Rodrigues Fernando M. Officer 9,572 $70.8K 2026-06-03 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2026-06-02 DIVITA CHARLES III Officer, Director 19,132 $145.9K 2026-06-02 Fidelity Brokerage Services LLC — EDGAR
2026-06-02 Rodrigues Fernando M. Officer 5,677 $43.3K 2026-06-02 Fidelity Brokerage Services LLC — EDGAR
2026-06-02 Vandervoort Adam C Officer 7,906 $60.3K 2026-06-02 Fidelity Brokerage Services LLC — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
79 ETFs hold TDOC
25 shown · $282.23M total exposure · 0.05% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 AVUV Avantis U.S. Small Cap Value ETF Avantis 0.17% $53.0M $32.2B 2026-10-23
2 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $33.3M — 2026-09-30
3 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.04% $29.0M $74.6B 2026-10-23
4 VB Vanguard Morningstar Small-Cap ETF Vanguard 0.01% $23.7M — 2026-09-30
5 DFSV Dimensional US Small Cap Value ETF Dimensional 0.08% $22.3M — 2026-10-23
6 VBR Vanguard Morningstar Small-Cap Value ETF Vanguard 0.02% $15.4M — 2026-09-30
7 VXF Vanguard Extended Market ETF Vanguard 0.01% $11.9M — 2026-09-30
8 DFAT Dimensional US Targeted Value ETF Dimensional 0.04% $11.9M — 2026-10-23
9 IWN iShares Russell 2000 Value ETF iShares (BlackRock) 0.08% $10.8M $13.9B 2026-10-23
10 FNDA Schwab Fundamental U.S. Small Company ETF Nport 0.08% $7.4M — 2026-05-31
11 DFAS Dimensional US Small Cap ETF Dimensional 0.02% $7.2M — 2026-10-23
12 PSC Principal U.S. Small-Cap ETF Nport 0.29% $6.7M — 2026-06-30
13 FESM Fidelity Enhanced Small Cap Core ETF Fidelity 0.10% $6.6M $6.6B 2026-10-23
14 SCHA Schwab U.S. Small-Cap ETF Nport 0.03% $6.5M — 2026-05-31
15 VTWO Vanguard Russell 2000 ETF Vanguard 0.03% $6.1M — 2026-09-30
16 BSVO EA Bridgeway Omni Small-Cap Value ETF Nport 0.24% $5.8M — 2026-06-30
17 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.01% $4.3M — 2026-10-23
18 SMLF iShares U.S. Small-Cap Equity Factor ETF iShares (BlackRock) 0.09% $3.9M $4.2B 2026-10-23
19 VHT Vanguard Health Care ETF Vanguard 0.01% $3.2M — 2026-09-30
20 KOMP State Street® SPDR® S&P Kensho New Economies Composite ETF SPDR (State Street) 0.11% $2.7M $2.5B 2026-10-23
21 DFMC Dimensional US Micro Cap ETF Dimensional 0.03% $2.6M — 2026-10-23
22 AVSC Avantis U.S. Small Cap Equity ETF Avantis 0.07% $2.2M $3.2B 2026-10-23
23 GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Goldman 0.19% $2.0M $1.0B 2026-10-23
24 IHF iShares U.S. Healthcare Providers ETF iShares (BlackRock) 0.14% $2.0M $1.4B 2026-10-23
25 ITOT iShares Core S&P Total U.S. Stock Market ETF iShares (BlackRock) 0.00% $1.5M $96.5B 2026-10-23
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-0.99
TTM Revenue
$2.49B
TTM Net Income
$-177.40M
TTM Op. Cash Flow
$261.18M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$606.93M$-38.91M$-0.21$64.66M
Q1 '262026-03-31$613.85M$-63.84M$-0.36$9.52M
Q4 '252025-12-31$642.27M$-25.14M$-0.14$87.74M
Q3 '252025-09-30$626.44M$-49.51M$-0.28$99.26M
Q2 '252025-06-30$631.90M$-32.66M$-0.19$91.43M
Q1 '252025-03-31$629.37M$-93.01M$-0.53$15.92M
Q4 '242024-12-31$640.49M$-48.41M$-0.26$85.90M
Q3 '242024-09-30$640.51M$-33.28M$-0.19$110.17M
Q2 '242024-06-30$642.44M$-837.67M$-4.92$88.68M
Q1 '242024-03-31$646.13M$-81.89M$-0.49$8.92M
Q4 '232023-12-31$660.53M$-28.89M$-0.17$130.08M
Q3 '232023-09-30$660.24M$-57.07M$-0.35$105.60M
Q2 2026 • period ending 2026-06-30 • filed 2026-07-30
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
0.85
P/S
0.45
EV/EBITDA
1.53
EV/Sales
0.14
ROE
-13.5%
ROA
-6.4%
Div Yield
0.00%
FCF Yield
23.47%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$1.11B
as of 2026-10-26
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
30.10M
SI % of Float
16.67%
Days to Cover
8.93
Short Vol Ratio
55.1%
Free Float
180.59M
Float %
99.4%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-08-14